The podcast explores the concept of virtual clinical trials, also known as in silico trials, where experiments are conducted entirely on silicon chips. This approach has the potential to revolutionize the way we test new drugs and treatments, making it faster, cheaper, and more accurate. The episode delves into the different types of virtual clinical trials, including synthetic control arms, quantitative systems pharmacology, and digital twins.
virtual clinical trialsin silico trialsdigital twinssynthetic control armsquantitative systems pharmacologyphysiologically based pharmacokinetic modelsorgans on chips
Use real-world data to create a virtual control group
Reduce the need for human subjects in clinical trials
Can be used for rare diseases where recruitment is difficult
Quantitative Systems Pharmacology
Models the disease and the drug together
Simulates the battle inside the body
Can predict how a drug will work in different patients
Physiologically Based Pharmacokinetic Models
Treat the body like a series of interconnected compartments
Calculate the flow of the drug between compartments
Can be used for pediatric dosing and extrapolating safety
Digital Twins
Dynamic, living replicas of a person's biology
Updated with real-time data and genomics
Can be used for personalized medicine
Episode Summary
check_circleVirtual clinical trials, or in silico trials, are a new approach to testing drugs and treatments that uses computer simulations instead of human subjects.
check_circleThe industry is shifting from a model that relies on biological guinea pigs to one that relies on digital twins.
check_circleThere are five distinct approaches to virtual clinical trials: synthetic control arms, quantitative systems pharmacology, physiologically based pharmacokinetic models, digital twins, and organs on chips.
check_circleSynthetic control arms use real-world data to create a virtual control group, reducing the need for human subjects in clinical trials.
check_circleQuantitative systems pharmacology models the disease and the drug together, simulating the battle inside the body.
check_circlePhysiologically based pharmacokinetic models treat the body like a series of interconnected compartments, calculating the flow of the drug between them.
check_circleDigital twins are dynamic, living replicas of a person's biology, updated with real-time data and genomics.
check_circleOrgans on chips are microphysiological systems that mimic the function of human organs, providing a bridge between the code and the creature.
check_circleThe math behind virtual clinical trials is rigorous, using techniques such as Latin hypercube sampling and cost functions to create realistic virtual patients.
check_circleThe accuracy of virtual clinical trials is startling, with one company achieving 90% accuracy in predicting the outcome of clinical trials.
Microphysiological systems that mimic the function of human organs
Provide a bridge between the code and the creature
Can be used to test drugs and treatments
check_circleThe financial impact of virtual clinical trials is significant, with the potential to save millions of dollars and cut enrollment time by months.
check_circleRegulators are moving to accept virtual clinical trials, with the FDA Modernization Act 2.0 authorizing non-animal methods.
check_circleHowever, there are still challenges to overcome, including emergent behaviors and unknown unknowns, bias in training data, and identifiability issues.
check_circleAI is being used to improve virtual clinical trials, with foundation models and causal AI being used to find new drug targets and optimize trials.